Providing a diverse range of perspectives from bullish to bearish, 7 analysts have published ratings on Globe Life (NYSE:GL) in the last three months.

The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.

Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $98.29, a high estimate of $118.00, and a low estimate of $65.00. Witnessing a positive shift, the current average has risen by 8.52% from the previous average price target of $90.57.

Interpreting Analyst Ratings: A Closer Look

A clear picture of Globe Life's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

Key Insights:

Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Globe Life's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.

Stay up to date on Globe Life analyst ratings.

About Globe Life

Breaking Down Globe Life's Financial Performance

Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.

Revenue Growth: Globe Life displayed positive results in 3 months. As of 30 June, 2024, the company achieved a solid revenue growth rate of approximately 8.58%. This indicates a notable increase in the company's top-line earnings. When compared to others in the Financials sector, the company faces challenges, achieving a growth rate lower than the average among peers.

Net Margin: Globe Life's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 17.94%, the company showcases strong profitability and effective cost management.

Return on Equity (ROE): Globe Life's ROE surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.03% ROE, the company effectively utilizes shareholder equity capital.

Return on Assets (ROA): Globe Life's ROA excels beyond industry benchmarks, reaching 0.91%. This signifies efficient management of assets and strong financial health.

Debt Management: Globe Life's debt-to-equity ratio is below the industry average. With a ratio of 0.44, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.

How Are Analyst Ratings Determined?

Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.

Analysts may enhance their evaluations by incorporating forecasts for metrics like growth estimates, earnings, and revenue, delivering additional guidance to investors. It is vital to acknowledge that, although experts in stocks and sectors, analysts are human and express their opinions when providing insights.

Which Stocks Are Analysts Recommending Now?

Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.

This article was generated by Benzinga's automated content engine and reviewed by an editor.